iodine 131-6-beta-iodomethyl-19-norcholesterol
Term · Oncology and biomedicine · MLC-T-ONC-014495
A radioiodine-labeled cholesterol analogue with radioisotopic activity. Iodine 131-l-6-beta-iodomethyl-19-norcholesterol accumulates in tissues where steroid hormones are produced, including the adrenal cortex and, to a lesser extent, the ovaries and the testes. After binding to low-density lipoprotein (LDL) receptors in the adrenal cortex, this agent is internalized, permitting scintigraphic localization of areas of adrenocortical glucocorticoid, mineralocorticoid and androgen secretion, and the scintigraphic assessment of adrenocortical function.
| Identifier | MLC-T-ONC-014495 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | iodine-131 NP-59 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-014495",
"term": "iodine 131-6-beta-iodomethyl-19-norcholesterol",
"field": "Oncology and biomedicine",
"definition": "A radioiodine-labeled cholesterol analogue with radioisotopic activity. Iodine 131-l-6-beta-iodomethyl-19-norcholesterol accumulates in tissues where steroid hormones are produced, including the adrenal cortex and, to a lesser extent, the ovaries and the testes. After binding to low-density lipoprotein (LDL) receptors in the adrenal cortex, this agent is internalized, permitting scintigraphic localization of areas of adrenocortical glucocorticoid, mineralocorticoid and androgen secretion, and the scintigraphic assessment of adrenocortical function.",
"synonyms": [
"iodine-131 NP-59"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/iodine-131-6-beta-iodomethyl-19-norcholesterol/"
}
Record 9,475 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.